Royalty Pharma Plc

Stock Chart, Company Information, and Scan Results

$54.87(as of Jun 12, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Royalty Pharma Plc Company Information, Fundamentals, and Technical Indicators

Stock Price$54.87
Ticker SymbolRPRX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees100
CountyUSA
Market Cap$32,033.5M

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

Royalty Pharma Plc In Our Stock Scanner

As of Jun 12, 2026
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.